LEXEO Therapeutics
Our mission is to transform healthcare by pushing boundaries in developing meaningful genetic medicines for diseases, regardless of prevalence. Our vision is a world where genetic medicines resolve the burden of disease, transforming all aspects of society. Based in New York City, Lexeo is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.
This company is:
Keywords
Industries
Where is LEXEO Therapeutics located?
The company LEXEO Therapeutics is located in New York, New York, United States. It's worth noting that the company may has more corporate locations
How many employees does LEXEO Therapeutics approximately have?
As of the latest available information LEXEO Therapeutics has around 11-50 employees worldwide.
When was LEXEO Therapeutics founded?
LEXEO Therapeutics was founded in 2018
In which industries does LEXEO Therapeutics mainly work?
The company LEXEO Therapeutics has it's main focus in the industries of Biotechnology
Lexicon Pharmaceuticals
United States
251-500 Employees
1995
LEX Diagnostics
United Kingdom
11-50 Employees
2020
Life Edit
United States
11-50 Employees
2017
StrideBio
United States
51-100 Employees
2015
Lexogen GmbH
Austria
51-100 Employees
2007
BridgeBio Pharma
United States
251-500 Employees
2014
LYSOGENE
France
11-50 Employees
2009
Biolexica
United States
1-10 Employees
2003
Topics which have been searched by others and may be interesting for you:
